Houston company’s immunotherapy treatment gets special FDA status – Chron.com
Chron.com |
Houston company's immunotherapy treatment gets special FDA status
Chron.com Viralym-C is described by its maker as a ready-to-administer T-cell immunotherapy product. In addition to orphan drug designation, the federal agency also granted it Fast Track status, the company said. Orphan drug designation is the special status … |
